0
How does Irinotecan affect the survival of colon cancer patients?
GaleEncyofMedicine
Irinotecan does not seem to increase toxicity but it improved response rates to 39%, added two to three months to disease-free survival, and prolonged overall survival by a little over two months.
Wiki User
∙ 13y ago
Add your answer:
Earn +20 pts
Is Irinotecan a good second line chemo for stage 4 colon cancer?
Yes, irinotecan is primarily indicated for advanced and metastatic colon cancer.
Why does irinotecan increase risk for diarrhea and neutropenia?
Irinotecan targets actively dividing cells in your body. In cases of cancer, this is a good thing because it stops rapidly dividing cancer cells from growing. However, it can also affect other tissues of your body that have high turnover rate, including the bone marrow and epithelial lining of the intestine. Hence, irinotecan increases the risk of diarrhea and neutropenia.
What are two things that influence cancer survival?
The patients attitude, and what stage the cancer was found in.
How is astragalus used to treat cancer patients?
Cancer patients who take astragalus during or after cancer treatments tend to recover more quickly from the ill effects of the treatment, and they generally have better survival rates.
Statistics for overall 5-year survival rate for patients with primary bone cancer?
80% survival rate in adults, 75% in children
What surgical results give a liver cancer patient the best chances for survival?
Patients who can have their entire tumor removed have the best chance for survival.
What is the survival rate for liver cancer patients who have all of their visible tumor removed?
If the entire visible tumor can be removed, about 25% of patients will be cured.
Which breast cancer patients have the worst chance for survival?
Persons who have cancerous spread to other distant places within the body (metastases) have stage IV cancer and the worst prognosis (potential for survival).
What is the five year survival rate for anaplastic thyroid cancer?
Only 3-17% of patients with anaplastic cancer survive for five years.
What are the survival rates for medullary thyroid cancer?
Eighty percent of patients with medullary thyroid cancer will live for at least 10 years after surgery.
Which breast cancer patients have the best chance for survival?
The breast cancer survival rate varies greatly on the patient and their response to treatment. Breast cancer survival rates for early detection are 100%. Stage 2 breast cancer has a survival rate of 93 percent, the stage 3 survival rate is 72 percent, and the stage 4 survival rate is 22 percent.
What are the survival rates for thyroid cancer?
Thyroid cancer is generally associated with very high survival rates. The prognosis for thyroid cancer is often favorable, with the majority of patients surviving the disease. Survival rates can vary depending on the specific type and stage of thyroid cancer. Here are some general survival rate statistics: Papillary Thyroid Cancer: Papillary thyroid cancer, the most common type, has a high survival rate. The 5-year relative survival rate for localized papillary thyroid cancer is approximately 99%, meaning that almost all patients with localized disease are alive 5 years after diagnosis. Even for regional (spread to nearby lymph nodes) or distant (metastatic) disease, the 5-year survival rate remains relatively high at around 93%. Follicular Thyroid Cancer: Follicular thyroid cancer also has favorable survival rates. The 5-year relative survival rate for localized disease is approximately 97%. For regional disease, it's about 86%, and for distant disease, it's around 67%. Medullary Thyroid Cancer: Medullary thyroid cancer has slightly lower survival rates compared to papillary and follicular types. For localized disease, the 5-year relative survival rate is around 98%. For regional disease, it's about 89%, and for distant disease, it drops to approximately 41%. Anaplastic Thyroid Cancer: Anaplastic thyroid cancer is the most aggressive form of thyroid cancer, and survival rates are much lower. The 5-year relative survival rate for this type is generally less than 10%, and many cases are fatal.
